Ihssan Elouarith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ihssan Elouarith has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Basma El Khannoussi
Pathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
2 shared publications - Mouna Khmou
Pathology Department, Faculty of Medicine and Pharmacy, Oncology National Institute, Mohammed V University, Rabat 10100, Morocco
2 shared publications - Salma Elmajoudi
Univ Mohammed 5, CHU Ibn Sina, Lab Anat Pathol, Rabat, Morocco
2 shared publications - Soumaya Ech-Charif
Pathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
2 shared publications - Youssef Mahdi
Department of Pathology and Molecular Pathology, National Institute of Oncology, Rabat, Morocco
2 shared publications Ahmed Jahid
Pathology Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco
1 shared publication
Latest Publications
- Open Access
- 26 October 2022
- Published by SAGE Publications in Clinical Pathology
- Vol. 15
Two Cases of Hepatoblastoma in Adults
Adult hepatoblastoma is a rare tumor whose etiology and mechanisms of development are still incompletely understood. Imaging and biological tests such as AFP and liver enzymes are non-specific. Histologically, there are 2 histological variants: pure epithelial with 5 types (pure fetal, embryonal, small cell undifferentiated, cholangioblastic, and macrotrabecular), a mixed epithelial and a mesenchymal variant with or without a teratoid contingent. The main differential diagnosis concerns hepatocellular carcinoma. The treatment of hepatoblastoma in adults is not yet standardized and surgery remains the mainstay of treatment. In this report we aim to describe the clinical, pathological, and immunohistochemical features of this rare entity in adult patients and discuss the elements allowing its distinction from hepatocellular carcinoma (HCC).
- 26 October 2022
- Published by SAGE Publications in Clinical Pathology
- Vol. 15
Open AccessTwo Cases of Hepatoblastoma in Adults
Adult hepatoblastoma is a rare tumor whose etiology and mechanisms of development are still incompletely understood. Imaging and biological tests such as AFP and liver enzymes are non-specific. Histologically, there are 2 histological variants: pure epithelial with 5 types (pure fetal, embryonal, small cell undifferentiated, cholangioblastic, and macrotrabecular), a mixed epithelial and a mesenchymal variant with or without a teratoid contingent. The main differential diagnosis concerns hepatocellular carcinoma. The treatment of hepatoblastoma in adults is not yet standardized and surgery remains the mainstay of treatment. In this report we aim to describe the clinical, pathological, and immunohistochemical features of this rare entity in adult patients and discuss the elements allowing its distinction from hepatocellular carcinoma (HCC).
- Open Access
- 18 August 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 98 (C) , 107525
Thyroid metastasis revealing a lung adenocarcinoma
Introduction: Metastatic lung adenocarcinoma in the thyroid is very rare. The clinical presentation and the radiological findings for metastasis carcinoma are nonspecific and do not allow the distinction between metastatic lung carcinoma and primary thyroid tumor. Case presentation: We report the case of a pulmonary papillary adenocarcinoma revealed by a thyroid metastasis in a 62-year-old and non-smoker patient with no history of cancer. Discussion: Thyroid metastasis revealing a primary adenocarcinoma of lung is extremely rare. In the absence of a history of lung cancer, the histological appearance of a papillary adenocarcinoma localized in the thyroid can be misdiagnosed as a primary thyroid cancer given the non-specificity of the clinical, radiological and histological presentations. Immunohistochemical analysis and molecular studies are the gold standards for establishing the diagnosis of the primary site. Conclusion: In this report we aim to discuss the histological and immunohistochemical features of lung adenocarcinoma metastazing in thyroid gland through a literature review. We are also targeting to highlight the essential role of immunohistochemistry and molecular study for the confirmation of the primary pulmonary origin and to discuss therapy for patients with lung cancer metastatic in the thyroid [17]. Highlights:
- 18 August 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 98 (C) , 107525
Open AccessThyroid metastasis revealing a lung adenocarcinoma
Introduction: Metastatic lung adenocarcinoma in the thyroid is very rare. The clinical presentation and the radiological findings for metastasis carcinoma are nonspecific and do not allow the distinction between metastatic lung carcinoma and primary thyroid tumor. Case presentation: We report the case of a pulmonary papillary adenocarcinoma revealed by a thyroid metastasis in a 62-year-old and non-smoker patient with no history of cancer. Discussion: Thyroid metastasis revealing a primary adenocarcinoma of lung is extremely rare. In the absence of a history of lung cancer, the histological appearance of a papillary adenocarcinoma localized in the thyroid can be misdiagnosed as a primary thyroid cancer given the non-specificity of the clinical, radiological and histological presentations. Immunohistochemical analysis and molecular studies are the gold standards for establishing the diagnosis of the primary site. Conclusion: In this report we aim to discuss the histological and immunohistochemical features of lung adenocarcinoma metastazing in thyroid gland through a literature review. We are also targeting to highlight the essential role of immunohistochemistry and molecular study for the confirmation of the primary pulmonary origin and to discuss therapy for patients with lung cancer metastatic in the thyroid [17]. Highlights:
- Open Access
- 22 June 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 96 (C) , 107340
Primary intra-testicular rhabdomyosarcoma
Introduction: RMS is a highly aggressive neoplasm that represents the most common soft tissue sarcoma in children and adolescents. It occurs most frequently in the head, neck, and genitourinary tract. Intra-testicular localization remains exceptional and very few cases have been reported in the literature. Case presentation: We represent a case of a 16-year-old patient, with no medical and surgical history, who presented with a painless right scrotal mass. Imaging revealed a suspicious testicular mass with no other secondary location. The patient underwent a right inguinal orchidectomy and the anatomopathological study confirmed the diagnosis of intratesticular rhabdomyosarcoma. The patient subsequently was referred to the oncology department for chemotherapy (Agha et al., 2020). Discussion: Intra-testicular rhabdomyosarcoma is a very rare malignant mesenchymal tumor showing skeletal muscle differentiation. They are subclassified into four major histological subtypes: Embryonal, alveolar, pleomorphic and Spindle cell/sclerosing rhabdomyosarcoma. ERMS is the most common subtype. Diagnosis of ITRMS is based on anatomopathological examination. Surgery and chemotherapy remain the mainstay of treatment. Radiotherapy is useful for local recurrence and metastasis. Conclusion: In this report we aim to describe the clinical, pathological and immunohistochemical features of this rare entity, and to highlight the importance of an early diagnosis followed by treatment combining Radical inguinal orchiectomy and chemotherapy and its role in improving prognosis. Highlights:
- 22 June 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 96 (C) , 107340
Open AccessPrimary intra-testicular rhabdomyosarcoma
Introduction: RMS is a highly aggressive neoplasm that represents the most common soft tissue sarcoma in children and adolescents. It occurs most frequently in the head, neck, and genitourinary tract. Intra-testicular localization remains exceptional and very few cases have been reported in the literature. Case presentation: We represent a case of a 16-year-old patient, with no medical and surgical history, who presented with a painless right scrotal mass. Imaging revealed a suspicious testicular mass with no other secondary location. The patient underwent a right inguinal orchidectomy and the anatomopathological study confirmed the diagnosis of intratesticular rhabdomyosarcoma. The patient subsequently was referred to the oncology department for chemotherapy (Agha et al., 2020). Discussion: Intra-testicular rhabdomyosarcoma is a very rare malignant mesenchymal tumor showing skeletal muscle differentiation. They are subclassified into four major histological subtypes: Embryonal, alveolar, pleomorphic and Spindle cell/sclerosing rhabdomyosarcoma. ERMS is the most common subtype. Diagnosis of ITRMS is based on anatomopathological examination. Surgery and chemotherapy remain the mainstay of treatment. Radiotherapy is useful for local recurrence and metastasis. Conclusion: In this report we aim to describe the clinical, pathological and immunohistochemical features of this rare entity, and to highlight the importance of an early diagnosis followed by treatment combining Radical inguinal orchiectomy and chemotherapy and its role in improving prognosis. Highlights:
- Open Access
- 18 May 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (5) , rjac233
An unusual variant of lipoma: case report
Osteo-lipoma is a very rare benign tumor with a good prognosis. It is composed mainly of mature fatty tissue with a bony component. The diagnosis is based on the histological study, given the clinical and radiological characters that can simulate other benign or malignant pathologies. Osteosarcoma is the main differential diagnosis. The distinction between these two neoplasms is essential as the basis of the treatment is different. We report the case of a patient with a giant ossifying lipoma independent of bone tissue located in the thigh.
- 18 May 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (5) , rjac233
Open AccessAn unusual variant of lipoma: case report
Osteo-lipoma is a very rare benign tumor with a good prognosis. It is composed mainly of mature fatty tissue with a bony component. The diagnosis is based on the histological study, given the clinical and radiological characters that can simulate other benign or malignant pathologies. Osteosarcoma is the main differential diagnosis. The distinction between these two neoplasms is essential as the basis of the treatment is different. We report the case of a patient with a giant ossifying lipoma independent of bone tissue located in the thigh.
- Open Access
- 30 April 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (4) , rjac116
Breast metastasis 18 years after nephrectomy for renal cell carcinoma: a case report
Metastasis of renal clear cell carcinoma (RCC) to the breast is exceptional. Breast metastases of extra-mammary tumors are rare and usually involve melanoma, lymphoma or leukemia. We report the case of a patient with breast metastasis of renal clear cell carcinoma occurring 18 years after nephrectomy. A history of RCC should always raise suspicion about breast metastasis, a situation that remains exceptional and whose diagnosis relies on anatomopathology.
- 30 April 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (4) , rjac116
Open AccessBreast metastasis 18 years after nephrectomy for renal cell carcinoma: a case report
Metastasis of renal clear cell carcinoma (RCC) to the breast is exceptional. Breast metastases of extra-mammary tumors are rare and usually involve melanoma, lymphoma or leukemia. We report the case of a patient with breast metastasis of renal clear cell carcinoma occurring 18 years after nephrectomy. A history of RCC should always raise suspicion about breast metastasis, a situation that remains exceptional and whose diagnosis relies on anatomopathology.